124 related articles for article (PubMed ID: 19817330)
1. Estimating the risk of ovarian cancer.
Ebell MH
Am Fam Physician; 2009 Sep; 80(6):632-4. PubMed ID: 19817330
[No Abstract] [Full Text] [Related]
2. Cancer of the ovary.
Cannistra SA
N Engl J Med; 2004 Dec; 351(24):2519-29. PubMed ID: 15590954
[No Abstract] [Full Text] [Related]
3. Should you be screened for ovarian cancer?
Johns Hopkins Med Lett Health After 50; 2001 May; 13(3):3. PubMed ID: 14727590
[No Abstract] [Full Text] [Related]
4. Defining women at high risk of ovarian cancer.
Swisher EM; King MC
Cancer Res; 2007 Mar; 67(6):2902; author reply 2902-3. PubMed ID: 17363619
[No Abstract] [Full Text] [Related]
5. Diagnosing ovarian cancer.
Walker M; Sobel M
CMAJ; 2018 Oct; 190(42):E1259. PubMed ID: 30348741
[No Abstract] [Full Text] [Related]
6. Hereditary breast and ovarian cancer syndrome.
ACOG Committee on Practice Bulletins
Gynecol Oncol; 2009 Apr; 113(1):6-11. PubMed ID: 19309638
[No Abstract] [Full Text] [Related]
7. Socio-demographic and clinical profile of BRCA1/2 mutation carriers opting for prophylactic oophorectomy.
Dagan E; Gil S; Gershoni-Baruch R
Prev Med; 2008 May; 46(5):470-2. PubMed ID: 18255133
[No Abstract] [Full Text] [Related]
8. The effect of symptom duration in epithelial ovarian cancer on prognostic factors.
Menczer J; Chetrit A; Sadetzki S;
Arch Gynecol Obstet; 2009 Jun; 279(6):797-801. PubMed ID: 18936947
[TBL] [Abstract][Full Text] [Related]
9. Impact of androgen receptor cytosine-adenine-guanine polymorphisms on clinical outcome in BRCA mutation-associated epithelial ovarian cancers.
Li AJ; McAllister P; Karlan BY
Gynecol Oncol; 2010 Jan; 116(1):105-8. PubMed ID: 19818997
[TBL] [Abstract][Full Text] [Related]
10. Influence of race/ethnicity on genetic counseling and testing for hereditary breast and ovarian cancer.
Forman AD; Hall MJ
Breast J; 2009; 15 Suppl 1():S56-62. PubMed ID: 19775331
[TBL] [Abstract][Full Text] [Related]
11. Ovarian cancer screening and early detection.
Joyner AB; Runowicz CD
Womens Health (Lond); 2009 Nov; 5(6):693-9. PubMed ID: 19863472
[TBL] [Abstract][Full Text] [Related]
12. Ovarian cancer: real progress in early detection.
Johns Hopkins Med Lett Health After 50; 2005 Jan; 16(11):3, 7. PubMed ID: 15693151
[No Abstract] [Full Text] [Related]
13. ACOG Practice Bulletin No. 89. Elective and risk-reducing salpingo-oophorectomy.
ACOG
Obstet Gynecol; 2008 Jan; 111(1):231-41. PubMed ID: 18165419
[No Abstract] [Full Text] [Related]
14. Tubal and ovarian pathways to pelvic epithelial cancer: a pathological perspective.
Piek JM; Verheijen RH; van Diest PJ
Histopathology; 2009 Mar; 54(4):494-5. PubMed ID: 19309405
[No Abstract] [Full Text] [Related]
15. [Ovarian epithelial dysplasia: myth or reality? Review].
Chêne G; Penault-Llorca F; Le Bouëdec G; Mishellany F; Dauplat MM; Tardieu AS; Pomel C; Jaffeux P; Aublet-Cuvelier B; Pouly JL; Déchelotte P; Dauplat J
Gynecol Obstet Fertil; 2008; 36(7-8):800-7. PubMed ID: 18657463
[TBL] [Abstract][Full Text] [Related]
16. My friend says I should get a CA 125 test to check for ovarian cancer. Should I have this test done?
Mayo Clin Womens Healthsource; 2007 Sep; 11(9):8. PubMed ID: 17700510
[No Abstract] [Full Text] [Related]
17. Ovarian cancer patient with germline mutations in both BRCA1 and NBN genes.
Porhanova NV; Sokolenko AP; Sherina NY; Ponomariova DN; Tkachenko NN; Matsko DE; Imyanitov EN
Cancer Genet Cytogenet; 2008 Oct; 186(2):122-4. PubMed ID: 18940477
[No Abstract] [Full Text] [Related]
18. CA-125 as a biomarker for malignant transformation of endometriosis.
Check JH
Fertil Steril; 2009 May; 91(5):e35; author reply e36. PubMed ID: 19338996
[No Abstract] [Full Text] [Related]
19. [Prevention of ovarian cancer development].
Horiuchi A; Konishi I
Nihon Rinsho; 2004 Oct; 62 Suppl 10():597-600. PubMed ID: 15535315
[No Abstract] [Full Text] [Related]
20. StatBite: Ovarian cancer: risk of recurrence by stage of diagnosis.
J Natl Cancer Inst; 2009 Sep; 101(18):1234. PubMed ID: 19738164
[No Abstract] [Full Text] [Related]
[Next] [New Search]
